Co-Authors
                            
                            
                                This is a "connection" page, showing publications co-authored by   Sheila Weinmann   and   Allison Naleway.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            1.172
         
        
        
     
 
    
        
        - 
            Incidence of herpes zoster among varicella-vaccinated children, by number of vaccine doses and simultaneous administration of measles, mumps, and rubella vaccine. Vaccine. 2020 08 18; 38(37):5880-5884.
            
            
                Score: 0.174
             
- 
            Temporal Trends in the Incidence of Anogenital Warts: Impact of Human Papillomavirus Vaccination. Sex Transm Dis. 2020 03; 47(3):179-186.
            
            
                Score: 0.171
             
- 
            Incidence of Herpes Zoster Among Children: 2003-2014. Pediatrics. 2019 07; 144(1).
            
            
                Score: 0.163
             
- 
            Pregnancy Outcomes after Treatment for Cervical Cancer Precursor Lesions: An Observational Study. PLoS One. 2017; 12(1):e0165276.
            
            
                Score: 0.137
             
- 
            Pregnancy after treatment for cervical cancer precursor lesions in a retrospective matched cohort. PLoS One. 2015; 10(2):e0117525.
            
            
                Score: 0.121
             
- 
            Evaluation of a surveillance case definition for anogenital warts, Kaiser Permanente northwest. Sex Transm Dis. 2014 Aug; 41(8):496-500.
            
            
                Score: 0.116
             
- 
            Changes in Cervical Cytology Results and Human Papillomavirus Types Among Persons Screened for Cervical Cancer, 2007 and 2015-2017. J Low Genit Tract Dis. 2022 Apr 01; 26(2):135-139.
            
            
                Score: 0.049
             
- 
            Human Papillomavirus Vaccine Effectiveness Against HPV Infection: Evaluation of One, Two, and Three Doses. J Infect Dis. 2020 03 02; 221(6):910-918.
            
            
                Score: 0.043
             
- 
            Declines in HPV vaccine type prevalence in women screened for cervical cancer in the United States: Evidence of direct and herd effects of vaccination. Vaccine. 2019 06 27; 37(29):3918-3924.
            
            
                Score: 0.041
             
- 
            Myocarditis and pericarditis are rare following live viral vaccinations in adults. Vaccine. 2018 03 14; 36(12):1524-1527.
            
            
                Score: 0.037
             
- 
            Human Papillomavirus Vaccine Effectiveness Against Incident Genital Warts Among Female Health-Plan Enrollees, United States. Am J Epidemiol. 2018 02 01; 187(2):298-305.
            
            
                Score: 0.037
             
- 
            Reduction in Human Papillomavirus Vaccine Type Prevalence Among Young Women Screened for Cervical Cancer in an Integrated US Healthcare Delivery System in 2007 and 2012-2013. J Infect Dis. 2015 Dec 15; 212(12):1970-5.
            
            
                Score: 0.031
             
- 
            Cervical intraepithelial neoplasia grade 3 and adenocarcinoma in situ: comparison of ICD-9 codes and pathology results--Kaiser Permanente, United States, 2000-2005. Cancer Epidemiol Biomarkers Prev. 2013 Jun; 22(6):1129-32.
            
            
                Score: 0.026
             
- 
            Prevalence of HPV types in cervical specimens from an integrated healthcare delivery system: baseline assessment to measure HPV vaccine impact. Cancer Causes Control. 2013 Feb; 24(2):403-7.
            
            
                Score: 0.026